Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

New Drug Application (NDA): 020241
Company: GLAXOSMITHKLINE LLC
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
LAMICTAL LAMOTRIGINE 100MG TABLET;ORAL Prescription AB Yes No
LAMICTAL LAMOTRIGINE 150MG TABLET;ORAL Prescription AB Yes No
LAMICTAL LAMOTRIGINE 200MG TABLET;ORAL Prescription AB Yes No
LAMICTAL LAMOTRIGINE 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET;ORAL Discontinued None Yes No
LAMICTAL LAMOTRIGINE 25MG TABLET;ORAL Prescription AB Yes Yes
LAMICTAL LAMOTRIGINE 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET;ORAL Discontinued None Yes No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
12/27/1994 ORIG-1 Approval Type 1 - New Molecular Entity PRIORITY

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
09/25/2019 SUPPL-60 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020241s060,020764s053,022251s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/020241Orig1s060, 020764Orig1s053, 022251Orig1s024, 022115Orig1s026ltr.pdf
08/14/2019 SUPPL-59 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020241s059,020764s052,022251s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/020241Orig1s059, 020764Orig1s052, 022251Orig1s023, 022115Orig1s025ltr.pdf
06/27/2018 SUPPL-57 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020241s057lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/020241Orig1s057,020764Orig1s050,022115Orig1s023,022251Orig1s021ltr.pdf
07/23/2018 SUPPL-56 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020241s056,020764s049,022251s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/020241Orig1s056,020764Orig1s049,022115Orig1s022,022251Orig1s020ltr.pdf
05/18/2015 SUPPL-53 Efficacy-New Patient Population Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020241s053,020764s046,022251s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022251Orig1s017,020241Orig1s053,020764Orig1s046ltr.pdf
06/10/2014 SUPPL-52 Labeling-Medication Guide Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020241Orig1s052,020764Orig1s045,022251Orig1s016Lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/020241Orig1s052,020764Orig1s045,022251Orig1s016,022115Orig1s019ltr.pdf
03/24/2015 SUPPL-51 Labeling-Medication Guide Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020241s045s051lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020241Orig1s045,051,020764Orig1s038,044,022251Orig1s007,014,022115Orig1s011,018ltr.pdf
08/01/2012 SUPPL-50 Labeling-Medication Guide Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020241s050,020764s043,022251s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020241Orig1s050,020764Orig1s043,022251Orig1s013,022115Orig1s017ltr.pdf
11/29/2011 SUPPL-49 Labeling-Medication Guide Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020241s049,020764s042,022251s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020241s049,020764s042,022251s012,022115s016ltr.pdf
05/31/2011 SUPPL-48 REMS-Modified Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020241s048,020764s041,022251s011ltr.pdf
08/04/2011 SUPPL-47 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020241s047,020764s040,022251s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022115s013,020241s047,020764s040,022251s010ltr.pdf
03/24/2015 SUPPL-45 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020241s045s051lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020241Orig1s045,051,020764Orig1s038,044,022251Orig1s007,014,022115Orig1s011,018ltr.pdf
10/24/2010 SUPPL-44 Labeling-Medication Guide Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020241s043s044,020764s036s037,022251s005s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020241s043,s044,020764s036,s037,022251s005,s006ltr.pdf
10/24/2010 SUPPL-43 REMS-Proposal Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020241s043s044,020764s036s037,022251s005s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020241s043,s044,020764s036,s037,022251s005,s006ltr.pdf
12/30/2014 SUPPL-40 Labeling-Patient Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020241s035s040,020764s028s033,022251s002s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/020241s035s040,020764s028s033,022115s004s014,022251s002s009ltr.pdf
12/20/2013 SUPPL-39 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020241s039,020764s032,022251s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020241Orig1s039;020764Orig1s032;022251Orig1s001;022115Orig1s003ltr.pdf
04/23/2009 SUPPL-38 REMS-Proposal, Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020241s037s038,020764s030s031lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020241s037,s038,020764s030,s031ltr.pdf
04/23/2009 SUPPL-37 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020241s037s038,020764s030s031lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020241s037,s038,020764s030,s031ltr.pdf
05/08/2009 SUPPL-36 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022251,020764s029,020241s036lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020241s036,020764s029ltr.pdf
12/30/2014 SUPPL-35 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020241s035s040,020764s028s033,022251s002s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/020241s035s040,020764s028s033,022115s004s014,022251s002s009ltr.pdf
03/17/2006 SUPPL-29 Labeling

Label is not available on this site.

09/22/2006 SUPPL-27 Efficacy-New Indication Label (PDF)
Letter (PDF)
Review (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020241s10,s21,s25,s27,020764s3,s14,s18,s19,s20LTR.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/020764_s020_Lamictal-optimized.pdf
09/25/2006 SUPPL-26 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020241s10,s21,s25,s27,020764s3,s14,s18,s19,s20LTR.pdf
09/25/2006 SUPPL-25 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020241SLRs10s21s25s26s27,020764SLRs3s14s18s19s20lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020241s10,s21,s25,s27,020764s3,s14,s18,s19,s20LTR.pdf
09/25/2006 SUPPL-21 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020241s10,s21,s25,s27,020764s3,s14,s18,s19,s20LTR.pdf
04/04/2003 SUPPL-18 Labeling Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20241slr018ltr.pdf
06/20/2003 SUPPL-17 Efficacy-New Indication Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20241se1-017,20764se1-011_lamictal_lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20241se1-017,20764se1-011ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/020241_S017_020764_S011TOC.cfm
01/14/2004 SUPPL-16 Efficacy-Labeling Change With Clinical Data Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20241se8-016,20764se8-009ltr.pdf
02/23/2001 SUPPL-15 Labeling

Label is not available on this site.

09/08/2000 SUPPL-14 Labeling

Label is not available on this site.

06/12/2000 SUPPL-12 Manufacturing (CMC)

Label is not available on this site.

05/25/2001 SUPPL-11 Efficacy-Labeling Change With Clinical Data Label (PDF)
Review (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20764s5lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/020241_S011.pdf
09/25/2006 SUPPL-10 Labeling Label (PDF)
Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020241SLRs10s21s25s26s27,020764SLRs3s14s18s19s20lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020241s10,s21,s25,s27,020764s3,s14,s18,s19,s20LTR.pdf
06/08/1999 SUPPL-9 Manufacturing (CMC)

Label is not available on this site.

01/17/2003 SUPPL-8 Efficacy-New Indication Label (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020241s008lbl.pdf
05/10/1999 SUPPL-7 Manufacturing (CMC)

Label is not available on this site.

03/16/1998 SUPPL-6 Labeling

Label is not available on this site.

03/16/1998 SUPPL-5 Manufacturing (CMC)-Control

Label is not available on this site.

03/11/1997 SUPPL-4 Labeling

Label is not available on this site.

12/14/1998 SUPPL-3 Efficacy-New Indication Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20241s03lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20241s3ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020241s003.cfm
08/24/1998 SUPPL-2 Efficacy-New Indication Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20241s2lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20241s2ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020764a.cfm
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
09/25/2019 SUPPL-60 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020241s060,020764s053,022251s024lbl.pdf
08/14/2019 SUPPL-59 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020241s059,020764s052,022251s023lbl.pdf
07/23/2018 SUPPL-56 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020241s056,020764s049,022251s020lbl.pdf
06/27/2018 SUPPL-57 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020241s057lbl.pdf
05/18/2015 SUPPL-53 Efficacy-New Patient Population Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020241s053,020764s046,022251s017lbl.pdf
03/24/2015 SUPPL-51 Labeling-Medication Guide Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020241s045s051lbl.pdf
03/24/2015 SUPPL-45 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020241s045s051lbl.pdf
12/30/2014 SUPPL-40 Labeling-Patient Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020241s035s040,020764s028s033,022251s002s009lbl.pdf
12/30/2014 SUPPL-35 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020241s035s040,020764s028s033,022251s002s009lbl.pdf
06/10/2014 SUPPL-52 Labeling-Medication Guide Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020241Orig1s052,020764Orig1s045,022251Orig1s016Lbl.pdf
12/20/2013 SUPPL-39 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020241s039,020764s032,022251s001lbl.pdf
08/01/2012 SUPPL-50 Labeling-Medication Guide Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020241s050,020764s043,022251s013lbl.pdf
11/29/2011 SUPPL-49 Labeling-Medication Guide Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020241s049,020764s042,022251s012lbl.pdf
08/04/2011 SUPPL-47 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020241s047,020764s040,022251s010lbl.pdf
10/24/2010 SUPPL-44 Labeling-Medication Guide Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020241s043s044,020764s036s037,022251s005s006lbl.pdf
10/24/2010 SUPPL-43 REMS-Proposal Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020241s043s044,020764s036s037,022251s005s006lbl.pdf
05/08/2009 SUPPL-36 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022251,020764s029,020241s036lbl.pdf
04/23/2009 SUPPL-38 REMS-Proposal Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020241s037s038,020764s030s031lbl.pdf
04/23/2009 SUPPL-38 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020241s037s038,020764s030s031lbl.pdf
04/23/2009 SUPPL-37 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020241s037s038,020764s030s031lbl.pdf
09/25/2006 SUPPL-26 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf
09/25/2006 SUPPL-25 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020241SLRs10s21s25s26s27,020764SLRs3s14s18s19s20lbl.pdf
09/25/2006 SUPPL-21 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf
09/25/2006 SUPPL-10 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020241SLRs10s21s25s26s27,020764SLRs3s14s18s19s20lbl.pdf
09/25/2006 SUPPL-10 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf
09/22/2006 SUPPL-27 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf
06/20/2003 SUPPL-17 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20241se1-017,20764se1-011_lamictal_lbl.pdf
01/17/2003 SUPPL-8 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020241s008lbl.pdf
05/25/2001 SUPPL-11 Efficacy-Labeling Change With Clinical Data Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20764s5lbl.pdf
12/14/1998 SUPPL-3 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20241s03lbl.pdf
08/24/1998 SUPPL-2 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20241s2lbl.pdf

LAMICTAL

TABLET;ORAL; 100MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
LAMICTAL LAMOTRIGINE 100MG TABLET;ORAL Prescription Yes AB 020241 GLAXOSMITHKLINE LLC
LAMOTRIGINE LAMOTRIGINE 100MG TABLET;ORAL Prescription No AB 090607 ALEMBIC PHARMS LTD
LAMOTRIGINE LAMOTRIGINE 100MG TABLET;ORAL Prescription No AB 200694 ALKEM LABS LTD
LAMOTRIGINE LAMOTRIGINE 100MG TABLET;ORAL Prescription No AB 078956 AUROBINDO PHARMA
LAMOTRIGINE LAMOTRIGINE 100MG TABLET;ORAL Prescription No AB 077783 CIPLA
LAMOTRIGINE LAMOTRIGINE 100MG TABLET;ORAL Prescription No AB 076708 DR REDDYS LABS LTD
LAMOTRIGINE LAMOTRIGINE 100MG TABLET;ORAL Prescription No AB 090169 GLENMARK GENERICS
LAMOTRIGINE LAMOTRIGINE 100MG TABLET;ORAL Prescription No AB 079132 JUBILANT CADISTA
LAMOTRIGINE LAMOTRIGINE 100MG TABLET;ORAL Prescription No AB 078691 LUPIN LTD
LAMOTRIGINE LAMOTRIGINE 100MG TABLET;ORAL Prescription No AB 077420 MYLAN
LAMOTRIGINE LAMOTRIGINE 100MG TABLET;ORAL Prescription No AB 078625 RUBICON
LAMOTRIGINE LAMOTRIGINE 100MG TABLET;ORAL Prescription No AB 078525 TARO PHARM INDS
LAMOTRIGINE LAMOTRIGINE 100MG TABLET;ORAL Prescription No AB 076388 TEVA
LAMOTRIGINE LAMOTRIGINE 100MG TABLET;ORAL Prescription No AB 078947 TORRENT PHARMS
LAMOTRIGINE LAMOTRIGINE 100MG TABLET;ORAL Prescription No AB 090170 UNICHEM LABS LTD
LAMOTRIGINE LAMOTRIGINE 100MG TABLET;ORAL Prescription No AB 077633 ZYDUS PHARMS USA

TABLET;ORAL; 150MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
LAMICTAL LAMOTRIGINE 150MG TABLET;ORAL Prescription Yes AB 020241 GLAXOSMITHKLINE LLC
LAMOTRIGINE LAMOTRIGINE 150MG TABLET;ORAL Prescription No AB 090607 ALEMBIC PHARMS LTD
LAMOTRIGINE LAMOTRIGINE 150MG TABLET;ORAL Prescription No AB 200694 ALKEM LABS LTD
LAMOTRIGINE LAMOTRIGINE 150MG TABLET;ORAL Prescription No AB 078956 AUROBINDO PHARMA
LAMOTRIGINE LAMOTRIGINE 150MG TABLET;ORAL Prescription No AB 077783 CIPLA
LAMOTRIGINE LAMOTRIGINE 150MG TABLET;ORAL Prescription No AB 076708 DR REDDYS LABS LTD
LAMOTRIGINE LAMOTRIGINE 150MG TABLET;ORAL Prescription No AB 090169 GLENMARK GENERICS
LAMOTRIGINE LAMOTRIGINE 150MG TABLET;ORAL Prescription No AB 079132 JUBILANT CADISTA
LAMOTRIGINE LAMOTRIGINE 150MG TABLET;ORAL Prescription No AB 078691 LUPIN LTD
LAMOTRIGINE LAMOTRIGINE 150MG TABLET;ORAL Prescription No AB 077420 MYLAN
LAMOTRIGINE LAMOTRIGINE 150MG TABLET;ORAL Prescription No AB 078625 RUBICON
LAMOTRIGINE LAMOTRIGINE 150MG TABLET;ORAL Prescription No AB 078525 TARO PHARM INDS
LAMOTRIGINE LAMOTRIGINE 150MG TABLET;ORAL Prescription No AB 076388 TEVA
LAMOTRIGINE LAMOTRIGINE 150MG TABLET;ORAL Prescription No AB 078947 TORRENT PHARMS
LAMOTRIGINE LAMOTRIGINE 150MG TABLET;ORAL Prescription No AB 090170 UNICHEM LABS LTD
LAMOTRIGINE LAMOTRIGINE 150MG TABLET;ORAL Prescription No AB 077633 ZYDUS PHARMS USA

TABLET;ORAL; 200MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
LAMICTAL LAMOTRIGINE 200MG TABLET;ORAL Prescription Yes AB 020241 GLAXOSMITHKLINE LLC
LAMOTRIGINE LAMOTRIGINE 200MG TABLET;ORAL Prescription No AB 090607 ALEMBIC PHARMS LTD
LAMOTRIGINE LAMOTRIGINE 200MG TABLET;ORAL Prescription No AB 200694 ALKEM LABS LTD
LAMOTRIGINE LAMOTRIGINE 200MG TABLET;ORAL Prescription No AB 078956 AUROBINDO PHARMA
LAMOTRIGINE LAMOTRIGINE 200MG TABLET;ORAL Prescription No AB 077783 CIPLA
LAMOTRIGINE LAMOTRIGINE 200MG TABLET;ORAL Prescription No AB 076708 DR REDDYS LABS LTD
LAMOTRIGINE LAMOTRIGINE 200MG TABLET;ORAL Prescription No AB 090169 GLENMARK GENERICS
LAMOTRIGINE LAMOTRIGINE 200MG TABLET;ORAL Prescription No AB 079132 JUBILANT CADISTA
LAMOTRIGINE LAMOTRIGINE 200MG TABLET;ORAL Prescription No AB 078691 LUPIN LTD
LAMOTRIGINE LAMOTRIGINE 200MG TABLET;ORAL Prescription No AB 077420 MYLAN
LAMOTRIGINE LAMOTRIGINE 200MG TABLET;ORAL Prescription No AB 078625 RUBICON
LAMOTRIGINE LAMOTRIGINE 200MG TABLET;ORAL Prescription No AB 078525 TARO PHARM INDS
LAMOTRIGINE LAMOTRIGINE 200MG TABLET;ORAL Prescription No AB 076388 TEVA
LAMOTRIGINE LAMOTRIGINE 200MG TABLET;ORAL Prescription No AB 078947 TORRENT PHARMS
LAMOTRIGINE LAMOTRIGINE 200MG TABLET;ORAL Prescription No AB 090170 UNICHEM LABS LTD
LAMOTRIGINE LAMOTRIGINE 200MG TABLET;ORAL Prescription No AB 077633 ZYDUS PHARMS USA

TABLET;ORAL; 25MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
LAMICTAL LAMOTRIGINE 25MG TABLET;ORAL Prescription Yes AB 020241 GLAXOSMITHKLINE LLC
LAMOTRIGINE LAMOTRIGINE 25MG TABLET;ORAL Prescription No AB 090607 ALEMBIC PHARMS LTD
LAMOTRIGINE LAMOTRIGINE 25MG TABLET;ORAL Prescription No AB 200694 ALKEM LABS LTD
LAMOTRIGINE LAMOTRIGINE 25MG TABLET;ORAL Prescription No AB 078956 AUROBINDO PHARMA
LAMOTRIGINE LAMOTRIGINE 25MG TABLET;ORAL Prescription No AB 077783 CIPLA
LAMOTRIGINE LAMOTRIGINE 25MG TABLET;ORAL Prescription No AB 076708 DR REDDYS LABS LTD
LAMOTRIGINE LAMOTRIGINE 25MG TABLET;ORAL Prescription No AB 090169 GLENMARK GENERICS
LAMOTRIGINE LAMOTRIGINE 25MG TABLET;ORAL Prescription No AB 079132 JUBILANT CADISTA
LAMOTRIGINE LAMOTRIGINE 25MG TABLET;ORAL Prescription No AB 078691 LUPIN LTD
LAMOTRIGINE LAMOTRIGINE 25MG TABLET;ORAL Prescription No AB 077420 MYLAN
LAMOTRIGINE LAMOTRIGINE 25MG TABLET;ORAL Prescription No AB 078625 RUBICON
LAMOTRIGINE LAMOTRIGINE 25MG TABLET;ORAL Prescription No AB 078525 TARO PHARM INDS
LAMOTRIGINE LAMOTRIGINE 25MG TABLET;ORAL Prescription No AB 076388 TEVA
LAMOTRIGINE LAMOTRIGINE 25MG TABLET;ORAL Prescription No AB 078947 TORRENT PHARMS
LAMOTRIGINE LAMOTRIGINE 25MG TABLET;ORAL Prescription No AB 090170 UNICHEM LABS LTD
LAMOTRIGINE LAMOTRIGINE 25MG TABLET;ORAL Prescription No AB 077633 ZYDUS PHARMS USA

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English